Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Press Releases

Investor Relations

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Contact Us


All Releases
View Summary Aradigm Corporation Names Igor Gonda President, Chief Executive Officer
Aug 10, 2006
PDF 13.4 KB Add to Briefcase
View Summary Aradigm Corporation Reports Second Quarter 2006 Financial Results
Aug 10, 2006
PDF 18.2 KB Add to Briefcase
View Summary Aradigm Corporation Second Quarter 2006 Earnings and Conference Call Notification
Jul 27, 2006
PDF 11.1 KB Add to Briefcase
View Summary Aradigm and Novo Nordisk Execute Further Restructuring of Partnership
Jul 5, 2006
PDF 12.4 KB Add to Briefcase
View Summary Aradigm Granted Hearing on Nasdaq Delisting Determination
Jun 29, 2006
PDF 11.4 KB Add to Briefcase
View Summary Aradigm Announces Receipt of Nasdaq Staff Determination Letter; Company to Request Hearing
Jun 23, 2006
PDF 11.6 KB Add to Briefcase
View Summary Aradigm Corporation Receives Nasdaq Notice of Non-Compliance
May 24, 2006
PDF 11.2 KB Add to Briefcase
View Summary Aradigm Provides Further Comments on Restructuring and Cash Used in Operations
May 17, 2006
PDF 12.1 KB Add to Briefcase
View Summary Aradigm Reports First Quarter 2006 Financial Results and Corporate Restructuring
May 15, 2006
PDF 17.8 KB Add to Briefcase
View Summary Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
May 9, 2006
PDF 11.7 KB Add to Briefcase
View Summary Aradigm Announces Approval of Application to Transfer Stock Listing to Nasdaq Capital Markets
May 1, 2006
PDF 11.1 KB Add to Briefcase
View Summary Aradigm Announces Update by Novo Nordisk on AERx Inhaled Insulin Phase 3 Clinical Program
Apr 28, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm and Canadian Department of National Defence Extend AERx Liposomal Ciprofloxacin Development Program
Apr 26, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm Corporation First Quarter 2006 Earnings and Conference Call Notification
Apr 26, 2006
PDF 11.1 KB Add to Briefcase
View Summary Aradigm Corporation Applies to Transfer Listing to Nasdaq Capital Market
Apr 24, 2006
PDF 11.4 KB Add to Briefcase
View Summary Aradigm Corporation Receives Nasdaq Notice of Non-Compliance With Nasdaq Marketplace Rules
Mar 31, 2006
PDF 11.5 KB Add to Briefcase
View Summary Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program of Novel Treatment for Asthma
Mar 23, 2006
PDF 13.4 KB Add to Briefcase
View Summary Aradigm Reports Novo Nordisk to Initiate Additional Phase 3 Clinical Trials of AERx Diabetes Management System
Mar 7, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm Corporation to Present at the Cowen & Co. 26th Annual Health Care Conference
Feb 28, 2006
PDF 10.5 KB Add to Briefcase
View Summary Aradigm Announces Fourth Quarter and Year End 2005 Financial Results
Feb 22, 2006
PDF 16.9 KB Add to Briefcase
Showing 201-220 of 222 Page: 1 ... 9 10 11 12  Previous 20 | Next 20
= add release to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2017 Aradigm Corporation. All Rights Reserved.